NULOJIX 250 mg powder for concentrate for solution for infusion

  • Name:

    NULOJIX 250 mg powder for concentrate for solution for infusion

  • Company:
    info
  • Active Ingredients:

    Belatacept

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 04/09/19

files-icon(Click to Download)

XPIL

Summary of Product Characteristics last updated on medicines.ie: 4/9/2019

Click on this link to Download PDF directly

Bristol-Myers Squibb Pharma EEIG

Company Products

Medicine NameActive Ingredients
Medicine Name Baraclude 0.05 mg/ml oral solution Active Ingredients Entecavir monohydrate
Medicine Name Baraclude 0.5 mg film coated tablets Active Ingredients Entecavir monohydrate
Medicine Name Baraclude 1.0 mg film coated tablets Active Ingredients Entecavir monohydrate
Medicine Name Empliciti 300 mg and 400 mg powder for concentrate for solution for infusion Active Ingredients Elotuzumab
Medicine Name NULOJIX 250 mg powder for concentrate for solution for infusion Active Ingredients Belatacept
Medicine Name OPDIVO 10 mg/mL concentrate for solution for infusion Active Ingredients Nivolumab
Medicine Name ORENCIA 125 mg solution for injection in pre-filled pen Active Ingredients Abatacept
Medicine Name ORENCIA 250 mg powder for concentrate for solution for infusion Active Ingredients Abatacept
Medicine Name ORENCIA 50 mg, 87.5 mg and 125 mg solution for injection (pre-filled syringe) Active Ingredients Abatacept
Medicine Name Reyataz 150 mg Hard Capsules Active Ingredients Atazanavir sulfate
Medicine Name Reyataz 200 mg Hard Capsules Active Ingredients Atazanavir sulfate
Medicine Name Reyataz 300 mg Hard Capsules Active Ingredients Atazanavir sulfate
Medicine Name Sprycel 10 mg/mL powder for oral suspension Active Ingredients dasatinib monohydrate
Medicine Name Sprycel 20mg, 50mg, 70mg and 100mg Film-Coated Tablets Active Ingredients dasatinib monohydrate
Medicine Name Sustiva 50 mg , 100 mg , 200 mg Hard Capsules Active Ingredients Efavirenz
Medicine Name Sustiva 600 mg Film-coated Tablets Active Ingredients Efavirenz
Medicine Name Yervoy 5mg per ml concentrate for solution for infusion Active Ingredients ipilimumab
Medicine Name Zerit 30 mg capsules Active Ingredients Stavudine
Medicine Name Zerit 40 mg capsules Active Ingredients Stavudine
1 - 0 of 19 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 4 September 2019 PIL

Reasons for updating

  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

The UK and IE product information is updated to align with the EU product information following the revision to the contact details for the local representative for Germany. Please note that there are no other changes to the UK and IE product information other than the date of text revision (29 August 2019)

Updated on 4 September 2019 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The UK and IE product information is updated to align with the EU product information following the revision to the contact details for the local representative for Germany. Please note that there are no other changes to the UK and IE product information other than the date of text revision (29 August 2019)

Updated on 6 March 2019 PIL

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 6 March 2019 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Section 10 DATE OF REVISION OF THE TEXT: Updated to 28 Feb to reflect overall product information update to the patient leaflet (addition of alternative batch release site)

Updated on 22 February 2019 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 22 February 2019 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

Section 7: Change to MAH address

Updated on 6 August 2018 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may not be renewed (A)

Updated on 11 September 2017 PIL

Reasons for updating

  • Change to information for healthcare professionals

Updated on 11 September 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 5 April 2017 PIL

Reasons for updating

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 11 March 2016 PIL

Reasons for updating

  • Change to packaging
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Removal of black triangle

Updated on 15 January 2015 PIL

Reasons for updating

  • Addition of information on reporting a side effect.

Updated on 19 May 2014 PIL

Reasons for updating

  • Addition of information on reporting a side effect.

Updated on 15 March 2013 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to improve clarity and readability

Updated on 8 February 2012 PIL

Reasons for updating

  • New PIL for new product
  • New PIL for medicines.ie